Gastrokinetic and Gastroprotective Activity of Gasex
Keywords:
Gasex, Phenol red, HCl, gastrokinetic, gastroprotective, histopathologyAbstract
Present study was aimed to evaluate the gastrokinetic and gastroprotective effect of Gasex a polyherbal formulation in experimental models of phenol red test meal method for gastrokinetic activity and acid-induced gastrointestinal lesions for gastroprotective activity. Gasex at a dose of 500 and 1000 mg/kg showed statistically significant gastrokinetic activity by increasing the percentage of gastric emptying and small intestinal transit, the higher dose of Gasex was comparable to the reference standard Domeperidone (10 mg/kg). The higher dose of Gasex (1000 mg/kg) showed gastroprotective activity by significantly decreasing the gastric volume and mean gastric lesion score and the same was reflected in histopathological findings. The present finding highlights few of the underlying modes of action of Gasex in the successful management of various gastrointestinal conditions.
References
McPhee, Stephen J, Papadakis, Maxine A,
Tierney, Lawrence M. Current medical
diagnosis and treatment: Alimentary tract.46th
Edition; McGraw-Hill. 2007:549-554.
(http://flylib.com/books/en/2.857.1.20/1/)
Henry P. Parkman, John A Bonino.
Pharmacological management of chronic
gastroparesis. Practical gastroenterology.
June. 2007:45-59.
(http://www.practicalgastro.com/pdf/June07/Ju
ne07BoninoArticle.pdf)
Henry P Parkman, Richard W Mccallum.
Gastroparesis: Pathophysiology, presentation
and treatment. Springer science; Humana
press; Newyork. 2012: 80-81.
Charaka Samhita. Shri Gulabkunverba
Ayurvedic Society, Jamnagar, Ayurvedic
Mundranalaya, Jamnagar, 1949;Vol.
(IV):1952-2032.
Tamhane MD, Thorat SP, Rege NN,
Dahanukar SA. Effect of oral administration of
Terminalia chebula on gastric emptying: an
experimental study. J Postgrad Med
;43:12-13.
(http://www.jpgmonline.com/text.asp?1997/43/
/12/423)
Barquist E, Bonaz B, Martinez V, Rivier J,
Zinner MJ, Taché Y. Neuronal pathways
involved in abdominal surgery-induced gastric
ileus in rats. Am J Physiol. 1996;April
(4):888-94.
http://www.ncbi.nlm.nih.gov/pubmed/8967419
Suchitra AD, Dkhar SA, Shewade DG,
Shashindran CH. Relative efficacy of some
prokinetic drugs in morphine-induced
gastrointestinal transit delay in mice. World J
Gastroenterol 2003;9(4):779-783.
(http://www.wjgnet.com/1007-9327/9/779.pdf)
Martin E Edelsbrunner, Motoko Nakano and
Peter Holzer. Afferent signaling from the acidchallenged rat stomach is inhibited and gastric
acid elimination is enhanced by lafutidine.
BMC Gastroenterology. 2009;9:40.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC
/pdf/1471-230X-9-40.pdf
Sadiq Yusuf, Abdulkarim Agunub, Mshelia
Diana .The effect of Aloe vera A. Berger
(Liliaceae) on gastric acid secretion and acute
gastric mucosal injury in rats. Journal of
Ethnopharmacology. 2004;93:33–37.
http://www.sciencedirect.com/science/article/pi
i/S0378874104001199
Smout AJPM, Akkermans LMA. Stomach,
pylorus and proximal duodenum. In: Normal
and disturbed motility of the gastrointestinal
tract. Petersfield, UK: Wrightson Biomedical
Publishing Ltd. 1992:87-114.
Heikkinen M, Pikkarainen P, Takala J,
Rasanen H, Julkunen R. Etiology of
dyspepsia: four hundred unselected
consecutive patients in general practice.
Scand J Gastroenterol. 1995;6:519-523.
Parkman HP, Camilleri M, Farrugia G,
Mccallum RW, Bharucha AE, Mayer EA, Tack
JF, Spiller R, etal . Gastroparesis and
functional dyspepsia: excerpts from the
AGA/ANMS meeting Neurogastroenterol Motil.
;22:113–133.
Tack J, Lee KJ. Pathophysiology and
treatment of functional dyspepsia. J Clin
Gastroenterol. 2005;39:211-216.
http://journals.lww.com/jcge/Abstract/2005/050
Kong MF, Horowitz M, Jones KL, Wishart JM,
Harding PE. Natural history of
diabeticgastroparesis. Diabetes Care.
;22:503-507.
Jones KL, Russo A, Stevens JE, Wishart JM,
Berry MK, Horowitz M. Predictors of delayed
gastric emptying in diabetes. Diabetes Care.
; 24:1264-1269.
De Block CEM, De Leeuw IH, Pelckmans PA,
Callens D, Máday E, Van Gaal LF. Delayed
gastric emptying and autoimmunity in type I
diabetes. Diabetes Care. 2002; 25:912-917.
Strid H, Simrén M, Stotzer PO, Abrahamsson
H, Bjornsson ES. Delay in gastric emptying in
patients with chronic renal failure. Scand J
Gastroenterol. 2004;39:516-520.
Parkman HP, Camilleri M, Farrugia G,
Mccallum RW, Bharucha AE, Mayer EA, Tack
JF, Spiller R, etal . Gastroparesis and
functional dyspepsia: excerpts from the
AGA/ANMS meeting Neurogastroenterol Motil.
;22,113–133.
Trial of Gasex in Functional Dyspepsia. Probe.
;XX(3):208.
Shekar Kumar MG, Prasad SR and Mitra SK.
Evaluation of efficacy and safety of Gasex
syrup in functional dyspepsia. Indian Journal
of Clinical Practice. 2007;18(6):29-34.
Inder Singh, Ranbir Singh .Trial of Gasex and
Herbolax for Preparation of Patients before
radiological examination. Indian Medical
Journal. 1986;6(80):87-88.
Brogden RN, Carmine AA, Heel RC et al:
Domperidone: a review of its pharmacological
activity, pharmacokinetics and therapeutic
efficacy in the symptomatic treatment of
chronic dyspepsia and as an anti-emetic.
Drugs 1982;24:360-400.
Riyad A, McCallum RW: Metoclopramide:
pharmacology and clinical application. Ann
Intern Med. 1983;98:86-95.
Reyntjens AJ: Clinical pharmacology and
therapeutics of domperidone. Clin Res Rev.
;3:91-100.
Broekaert A: Effect of domperidone on gastric
emptying and secretion. Postgrad Medj
;55(suppl 1):11-14
Jacobs F, Akkermans LMA, Hongeo 0 et al:
Effects of domperidone on gastric emptying of
semi-solid and solid food. In Towse G (ed):
Progress with domperidone, a gastrokinetic
and anti-emetic agent. R Soc Med London.
;11-20.
Baeyens R, Van De Velde E, De Schepper A
et al: Effects of intravenous and oral
domperidone on the motor function of the
stomach and small intestine. Ibid: 19-23
Mohd. Ali, Palaniyamma. D. Gastroprotection
with Gasex tablets in GI disorders and
preradiographic preparation: A meta-analysis.
Indian Journal of Clinical Practice. January
21(8): 427-432Collings KL, et al. Aliment
Pharmacol Ther 2002;16(12):2029-35.
